Advisor Group Holdings, Inc. Vaccinex, Inc. Transaction History

Advisor Group Holdings, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.44 - $131.17 $44 - $13,116	-100 Reduced 2.78%	3,500 $2,000
Q3 2022 Nov 14, 2022	BUY	$0.48 - $109.22 $48 - $10,922	100 Added 2.86%	3,600 $2,000
Q1 2022 May 04, 2022	SELL	$0.92 - $1.94 $736 - $1,552	-800 Reduced 18.6%	3,500 $5,000
Q4 2020 Feb 10, 2021	SELL	$1.66 - $2.35 $5,893 - $8,342	-3,550 Reduced 45.22%	4,300 $9,000
Q3 2020 Nov 12, 2020	BUY	$1.75 - $8.19 $10,412 - $48,730	5,950 Added 313.16%	7,850 $14,000
Q1 2020 May 18, 2020	BUY	$3.96 - $8.37 $7,524 - $15,902	1,900 New	1,900 $7,000

426K

Ticker VCNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,664,100
Market Cap $49.1M
Description
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.